Polio endgame: the global introduction of inactivated polio vaccine (Q38322526)

2 September 2017

1 reference

title

Polio endgame: the global introduction of inactivated polio vaccine (English)

1 reference

2 September 2017

Manish Patel

1

1 reference

2 September 2017

Simona Zipursky

2

1 reference

2 September 2017

Walt Orenstein

3

1 reference

2 September 2017

Julie Garon

4

1 reference

2 September 2017

Michel Zaffran

5

1 reference

2 September 2017

19 January 2015

1 reference

Expert Review of Vaccines

2 September 2017

1 reference

2 September 2017

14

1 reference

2 September 2017

5

1 reference

2 September 2017

749-762

1 reference

Economic analysis of the global polio eradication initiative.

2 September 2017

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1001750

Current polio global eradication and control policy options: perspectives from modeling and prerequisites for oral poliovirus vaccine cessation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1001750

Oral poliovirus vaccine evolution and insights relevant to modeling the risks of circulating vaccine-derived polioviruses (cVDPVs).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1001750

VACCINE-DERIVED POLIOVIRUSES AND THE ENDGAME STRATEGY FOR GLOBAL POLIO ERADICATION *

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1001750

Systematic review of mucosal immunity induced by oral and inactivated poliovirus vaccines against virus shedding following oral poliovirus challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1001750

Polio eradication. Efficacy of inactivated poliovirus vaccine in India

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1001750

Risks of paralytic disease due to wild or vaccine-derived poliovirus after eradication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1001750

Global polio eradication initiative: lessons learned and legacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1001750

Vaccine-associated paralytic poliomyelitis: a review of the epidemiology and estimation of the global burden

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1001750

Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1001750

Persistence of vaccine-derived poliovirus following a mass vaccination campaign in Cuba: implications for stopping polio vaccination after global eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1001750

Poliovirus vaccination options for achieving eradication and securing the endgame

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1001750

Immunogenicity and effectiveness of routine immunization with 1 or 2 doses of inactivated poliovirus vaccine: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1001750

Defining surrogate serologic tests with respect to predicting protective vaccine efficacy: poliovirus vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1001750

Clinical efficacy of a new, enhanced-potency, inactivated poliovirus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1001750

Molecular characterization of poliovirus isolates from children who contracted vaccine-associated paralytic poliomyelitis (VAPP) following administration of monovalent type 3 oral poliovirus vaccine in the 1960s in Hungary.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1001750

Paralytic poliomyelitis associated with Sabin monovalent and bivalent oral polio vaccines in Hungary

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1001750

Effect of a single inactivated poliovirus vaccine dose on intestinal immunity against poliovirus in children previously given oral vaccine: an open-label, randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1001750

Randomized, placebo-controlled trial of inactivated poliovirus vaccine in Cuba

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1001750

Modeling the potential role of inactivated poliovirus vaccine to manage the risks of oral poliovirus vaccine cessation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1001750

Immunogenicity of a supplemental dose of oral versus inactivated poliovirus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1001750

Hexavalent IPV-based combination vaccines for public-sector markets of low-resource countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1001750

Experiences with provider and parental attitudes and practices regarding the administration of multiple injections during infant vaccination visits: lessons for vaccine introduction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1001750

Randomized controlled study of fractional doses of inactivated poliovirus vaccine administered intradermally with a needle in the Philippines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1001750

Safety and immunogenicity of inactivated poliovirus vaccine based on Sabin strains with and without aluminum hydroxide: a phase I trial in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1001750

A national reference for inactivated polio vaccine derived from Sabin strains in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1001750

10.1586/14760584.2015.1001750

21 January 2018

Identifiers

DOI

1 reference

2 September 2017

1 reference